OS Therapies Inc

NYSE:OSTX

Pharmaceutical Preparations·ROCKVILLE, MD

CEO

Romness Paul A.

CFO

Acevedo Christopher P.

Financials

7 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/18/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/15/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

5 shown

Filed	Period
8/19/25	Q3 FY2025	→
5/16/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/15/24	Q4 FY2024	→
8/15/24	Q3 FY2024	→

News (8-K)

23 shown

Filed	Type	Description
3/6/26	Agreement	Entry into a Material Definitive Agreement	→
2/13/26	Other	Other Events	→
1/12/26	Agreement	Entry into a Material Definitive Agreement	→
10/21/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/17/25	Reg FD	Regulation FD Disclosure	→
9/30/25	Other	Other Events	→
↓

Prospectuses & Registrations

23 shown

Filed	Form	Description
10/31/25	S-8	REGISTRATION STATEMENT	→
9/30/25	424B7	PROSPECTUS SUPPLEMENT	→
8/26/25	ARS	ARS	→
8/25/25	424B5	PROSPECTUS SUPPLEMENT	→
8/25/25	424B3	424B3	→
8/8/25	S-3	REGISTRATION STATEMENT	→
↓

Filing History(201 filings)

TypeDateAccessionPeriodSize

Mar 6, 2026

0001795091-26-000002

—

12.8 KB

8-K

Mar 6, 2026

0001213900-26-024726CURRENT REPORT

Mar 4, 2026

821.0 KB

Feb 13, 2026

0001213900-26-016508

Jan 22, 2026

6.2 KB

Feb 13, 2026

0001213900-26-016506

Jan 22, 2026

7.1 KB

Feb 13, 2026

0001213900-26-016503

Jan 22, 2026

7.1 KB

Feb 13, 2026

0001213900-26-016501

Jan 22, 2026

6.2 KB

Feb 13, 2026

0001213900-26-016499

Jan 22, 2026

6.3 KB

Feb 13, 2026

0001213900-26-016497

Jan 22, 2026

6.2 KB

Feb 13, 2026

0001213900-26-016495

Jan 22, 2026

5.7 KB

Feb 13, 2026

0001213900-26-016494

Jan 22, 2026

5.6 KB

4/A

Feb 13, 2026

0001213900-26-016435

Oct 21, 2025

6.7 KB

8-K

Feb 13, 2026

0001213900-26-016408CURRENT REPORT

Feb 10, 2026

188.6 KB

Jan 20, 2026

0001795091-26-000001

—

12.8 KB

8-K

Jan 12, 2026

0001213900-26-003166CURRENT REPORT

Jan 10, 2026

457.6 KB

Dec 19, 2025

0001213900-25-124000

Oct 21, 2025

7.1 KB

Dec 19, 2025

0001213900-25-123999

Oct 21, 2025

6.3 KB

Dec 19, 2025

0001213900-25-123998

Oct 21, 2025

6.2 KB

Dec 19, 2025

0001213900-25-123996

Oct 21, 2025

5.7 KB

Dec 19, 2025

0001213900-25-123995

Oct 21, 2025

5.6 KB

Dec 19, 2025

0001213900-25-123994

Oct 21, 2025

7.1 KB

Dec 19, 2025

0001213900-25-123993

Oct 21, 2025

6.2 KB

Dec 19, 2025

0001213900-25-123992

Oct 21, 2025

6.2 KB

10-Q

Nov 14, 2025

0001213900-25-110829QUARTERLY REPORT

Sep 30, 2025

6.3 MB

S-8

Oct 31, 2025

0001213900-25-104724REGISTRATION STATEMENT

—

259.4 KB

8-K

Oct 21, 2025

0001213900-25-100821CURRENT REPORT

Oct 21, 2025

371.7 KB

25 filings shown

Filed	Form	Description
10/17/25	DEFA14A	DEFA14A	→
8/25/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
8/25/25	DEF 14A	DEF 14A	→
8/15/25	PRE 14A	PRE 14A	→
4/2/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
2/28/25	DEF 14A	DEF 14A	→
↓

OS Therapies Inc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(201 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	D	D	→
1/20/26	D	D	→
9/10/25	D	D	→
8/25/25	EFFECT	EFFECT	→
8/18/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓